News Overview

July 1, 2009

Bayer files patent infringement lawsuit against Teva
» more

June 29, 2009

Bayer CropScience and Monsanto sign cross licensing agreement on herbicide tolerance traits in rapeseed/canola
» more

1:10 min.

June 25, 2009

New choices for corn and soybean farmers worldwide:
Bayer CropScience and DuPont expand collaboration with broad license agreements
» more

June 16, 2009

Innovation in sulfuric acid production
Bayer Technology Services completed sulfuric acid plant featuring innovative technology
» more

1:24 min.

June 2, 2009

Bayer HealthCare and Genzyme Finalize Strategic Alliance Agreement
» more

June 1, 2009

Bayer and Onyx Initiate Phase III Trial of Nexavar® in Non-small Cell Lung Cancer
» more

1:21 min.

May 30, 2009

45th American Society of Clinical Oncology Annual Meeting (ASCO):
Bayer Schering Pharma Announces New Data on Novel Anti-cancer Compound BAY 73-4506
» more

1:43 min.

May 28, 2009

Venous Blood Clot Prevention after Hip or Knee Replacement Surgery:
U.S. FDA Issues Complete Response Letter for Rivaroxaban
» more

May 28, 2009

Phase III Trial Started to Evaluate Combination Therapy of Nexavar® and Tarceva® in Patients with Liver Cancer
» more

1:21 min.

May 26, 2009

Sustainable Development Report 2008 published:
Bayer: Successful and sustainable business
» more

May 22, 2009

Milestone for the cotton-pipeline
U.S. Department of Agriculture grants approval for Bayer CropScience’s GlyTol™ cotton technology
» more

May 20, 2009

Nexavar® Approved in Japan for the Treatment of Advanced Liver Cancer
» more

1:08 min.

May 19, 2009

American Thoracic Society (ATS) congress, San Diego, USA:
Bayer Schering Pharma presents positive results of phase II study with Riociguat
» more

May 14, 2009

Qlaira® – innovative estradiol-based oral contraceptive available in Europe from May onwards
» more

May 12, 2009

Werner Wenning at the Bayer AG Annual Stockholders’ Meeting
“Corporate strategy proves effective in a difficult environment”
» more

5:31 min.

1:21 min.

May 5, 2009

Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch
» more

0:51 min.

April 30, 2009

Bayer and Regeneron extend development program for VEGF Trap-Eye
» more

1:11 min.

April 29, 2009

Bayer interim report for the first quarter of 2009
CropScience and Pharmaceuticals continue on a path of growth – Slump in business at MaterialScience leaves a distinct mark
» more

April 28, 2009

Bayer and Ardea Biosciences Enter Global Agreement Focused on the Development of MEK Inhibitors for the Treatment of Cancer
» more

1:36 min.

April 27, 2009

Phase III Trial of Nexavar® in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint
» more

more News